Embryonic stem cells for treating blindness

Researchers at Karolinska Institutet and St Erik Eye Hospital in Sweden have discovered a way to refine the production of retinal cells from embryonic stem cells for treating blindness in the elderly.

Using CRISPR/Cas9 gene editing, they also modified the cells so that they can hide from the immune system to prevent rejection.